• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Blog
  • News & Events
  • Videos
  • Resources
main-logo-small

Compliance Architects

Consulting Technology Outsourcing

  • About Us
    • Senior Staff
    • Why Us
    • Mission And Vision
    • Clients
    • Partners
    • Career Opportunities
  • Services
    • Inspection Readiness & Enforcement
      • FDA Inspection Readiness
      • Audits & Assessments
      • FDA Enforcement Response/Remediation
    • FDA Quality Consulting
      • Quality System & Compliance Turnarounds / Restructuring
      • Training / Coaching
      • Quality & Compliance Computer-Based Systems
      • External Supply Chain Compliance
      • Part 11 & Computer Systems Validation
      • Turnkey Quality Systems
    • Quality Assurance and Engineering
      • CRPN Quality Roadmap®
      • Quality Culture Assessment
      • Product Quality Consulting
      • Operational Efficiency/Compliance Effectiveness
      • Project/Program Management
    • Corporate Compliance and Litigation
      • Corporate Compliance Programs
      • Interactions With Department Of Justice And The Courts
    • FDA Regulatory Consultants
      • Product Development / Submissions / Commercialization
      • REMS (Risk Evaluation And Mitigation Strategies)
      • Mergers / Acquisitions / Licensing
    • Quality, Compliance, Regulatory & Operations’ Staffing
      • Staffing
      • Talent Management
      • Rapid Turnaround
  • Innovative Solutions
    • Writing for Compliance®
    • CRPN Quality Roadmap®
    • Quality Pulse®
    • IEEP
    • REMS
  • Success Stories
  • Industries
    • Biopharmaceuticals
    • Cannabis/CBD
    • Cell & Gene Therapies
    • Combination Products
    • Cosmetics
    • Dietary Supplements
    • Medical Devices and Diagnostics
    • Pharmaceuticals
  • Contact Us

Dedicated, Integrated Quality Assurance Systems Critical to Successful Clinical Trials

The notion that the role of Quality Assurance (QA) in clinical development should be relegated to reviews, audits and quality control (QC) checks is an antiquated one that could well run medical product developers afoul of FDA and international regulations. The role of QA in clinical development has evolved significantly over the last two decades, and savvy companies will see that incorporating QA throughout the clinical study process can ensure that execution of the trial—including risk management—will meet both regulatory requirements and align with overall business strategy.

US regulations covering clinical trial conduct (21 CFR 50, 54, 56 and 312) do not specifically require a quality management system throughout all stages of trial design and execution, although some of the product sponsor responsibilities outlined in Section 312—such as auditing—are usually carried out by the QA unit. Because of this, QA’s role historical role in GCPs was often limited to auditing. But the FDA and international regulators have developed expectations beyond the bare regulations that reflect ever-evolving best practices. And simple compliance with US regulations is no longer enough. FDA and harmonized international guidances must be considered, as well as current industry standards and best practices.

Over the years, the evolution and intersection of QA and Good Clinical Practices (GCP) expectations have provided medical product companies with both responsibilities—in the form of compliance with regulations plus meeting expectations outlined in FDA and international guidances—and opportunities—the ability to define and re-define the roles and responsibilities of the quality unit supporting GCP compliance in ways that make the most sense in terms of meeting business goals.

A well-integrated GCP QA unit can add real value to costly clinical trials by focusing on overall excellence in study execution. Better execution yields better data, which can help speed a new product application through the FDA approval process with fewer hiccups along the way. This support can continue all the way through commercialization of new products. Specifically, the GCP QA can cover the following critical clinical trial roles and responsibilities:

Development, implementation and maintenance of the GCP quality system. This can include developing GCP quality metrics and implementing a quality management review process for senior management in a sponsor company’s research and development division. The system should focus on identifying all potential risks to trial reliability and GCP compliance and proposing actions to mitigate that risk in line with existing business needs and strategies.

From the quality metrics and related review plan will arise a risk-based GCP quality plan, including goals and objectives that are integrated into the overall business plan for the investigational new product.

Quality and compliance oversight of all GCP-related activities throughout clinical trial design, preparation and execution. This role should include review of the clinical trial protocol, the risk management plan and the oversight and monitoring plans, including scrutiny of informed consent forms and other essential documents, such as those referenced in pertinent FDA regulations and guidances like the International Conference on Harmonization (ICH) Guideline for Good Clinical Practice (E6).

Document review is particularly important. In this role, the QA unit may act as a prevention-focused quality engineer, ensuring not only that all documents meet pertinent regulatory requirements, but that they also are free from inconsistencies or problematic wording that could increase the likelihood of protocol deviations or violations. The unit also should look for opportunities to improve the informed consent form and the protocol itself in ways likely to reduce user error during both the informed consent process and during trial execution.

Establishment of a third-party supplier quality management process. This is important to ensure that CROs, laboratories, clinical investigators and others involved in clinical trials adhere to the sponsor’s QA/QC system and remain in compliance with current GCP and data integrity requirements. Specific activities conducted may include:

  • Development and implementation of supplier quality metrics, through which the sponsor may monitor GCP compliance by all material and service suppliers;
  • Periodic audits of third parties to ensure compliance;
  • Periodic internal audits of clinical operations, regulatory affairs, clinical development and medical safety units to ensure GCP and safety reporting compliance; and
  • Partnering with in-house GMP auditors for periodic auditors of R&D laboratories and production operations that support clinical trial material manufacture and testing.

Development and implementation of a risk management plan and process. Risk management is the watchword for FDA inspectors and sponsors need a solid plan in place to ensure that all potential risks associated with an investigational product and clinical trial are identified. Any risks deemed major or critical needs to be mitigated and communicated to senior management of the sponsor company. Periodic management review of the GCP quality system should be part of the process to ensure that senior management is aware of the nuts-and-bolts of the system and is able to prioritize actions to address critical quality and compliance risks.

Other key QA activities may include periodic GCP training for clinical operations, regulatory affairs, clinical development and medical safety staff and review of monitoring reports from site visits to ensure that identified issues are addressed promptly and appropriately, along with escalation of critical quality and compliance issues discovered during conduct of a clinical trial and preparing for and leading FDA Bioresearch Monitoring (BIMO) inspections.

Additionally, the QA unit should periodically report certain GCP quality and compliance metrics to the clinical operations, clinical development and regulatory affairs departments. These include:

  • Performance metrics for the contract research organizations (CROs) and principal investigators;
  • Protocol deviation trends;
  • Corrective and Preventive Action (CAPA) effectiveness in reducing critical risks to trial reliability;
  • Timeliness of safety reporting; and
  • Internal and external GCP audit findings.

Creating a GCP QA unit that covers these responsibilities will move sponsors to the head of the new product development pack. In order to successfully create an effective and compliant QA unit and system, however, companies must be well-versed not only in applicable regulations and guidances, but in current industry standards and best practices, which we will address in a forthcoming article.

Filed Under: Achieving Compliance, clinical trials, Quality Management & Assurance, Risk Management

Primary Sidebar

Sign Up To Our Newsletter

You May Also Like

Sue Soderholm to be a Featured Speaker at the 1st Annual Quality Management vSummit – “Optimizing Your Quality Management Program to Be Both World Class and FDA-Compliant” | Tuesday, October 11, 2022 – Wednesday, October 12, 2022

Achieve True Quality Culture and Stay Compliant If your quality management system (QMS) isn’t world class, you may be falling behind. You need the 1st Annual
life sciences staffing

Talk to us about current talent trends, and what the industry will need in the next 5 to 10 years?

Transcript taken from 2022 PMWS by Executive Platforms The talent crisis as it has been called is certainly not something that has gone away or

Preparing for an FDA Pre-Approval Inspection (PAI) – “Begin with the End in Mind.”

Presented by: Teresa Gorecki, Practice Lead, Compliance Architects What is it Steven Covey said in “The 7 Habits of Highly Effective People?” “Begin with the

Footer

Compliance Architects®

  • Contact Us
  • (888) 734-9778
  • info@compliancearchitects.com

Quick Links

  • About Us
    • Senior Staff
    • Why Us
    • Mission And Vision
    • Clients
    • Partners
    • Career Opportunities
  • Services
    • Inspection Readiness & Enforcement
      • FDA Inspection Readiness
      • Audits & Assessments
      • FDA Enforcement Response/Remediation
    • FDA Quality Consulting
      • Quality System & Compliance Turnarounds / Restructuring
      • Training / Coaching
      • Quality & Compliance Computer-Based Systems
      • External Supply Chain Compliance
      • Part 11 & Computer Systems Validation
      • Turnkey Quality Systems
    • Quality Assurance and Engineering
      • CRPN Quality Roadmap®
      • Quality Culture Assessment
      • Product Quality Consulting
      • Operational Efficiency/Compliance Effectiveness
      • Project/Program Management
    • Corporate Compliance and Litigation
      • Corporate Compliance Programs
      • Interactions With Department Of Justice And The Courts
    • FDA Regulatory Consultants
      • Product Development / Submissions / Commercialization
      • REMS (Risk Evaluation And Mitigation Strategies)
      • Mergers / Acquisitions / Licensing
    • Quality, Compliance, Regulatory & Operations’ Staffing
      • Staffing
      • Talent Management
      • Rapid Turnaround
  • Innovative Solutions
    • Writing for Compliance®
    • CRPN Quality Roadmap®
    • Quality Pulse®
    • IEEP
    • REMS
  • Success Stories
  • Industries
    • Biopharmaceuticals
    • Cannabis/CBD
    • Cell & Gene Therapies
    • Combination Products
    • Cosmetics
    • Dietary Supplements
    • Medical Devices and Diagnostics
    • Pharmaceuticals
  • Contact Us

Our Services

  • Inspection Readiness & Enforcement
  • FDA Quality Consulting – Systems and Training
  • Quality Assurance and Engineering
  • Corporate Compliance and Litigation Services
  • FDA Regulatory Consultants – Due Diligence
  • Quality, Compliance, Regulatory & Operations’ Staffing Services

Proprietary Solutions

  • Writing for Compliance®
  • Quality Pulse®
  • CRPN Quality Roadmap®

© 2009-2023 Compliance Architects Holdings LLC – used by permission. All copyrights, trademarks and other intellectual property are the property of Compliance Architects Holdings LLC and are used by permission.

  • Debarment Certification Statement
  • Privacy Policy
  • Terms of Use

Contact Us Today

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT